Announcements Trials

Browse Landscape

Phase

Phase 1 5 Phase 1/2 1

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 72 Breast Neoplasms 63 Neoplasms 59 Leukemia, Myeloid, Acute 59 Multiple Myeloma 53 Colorectal Neoplasms 48 Lymphoma 46 Recurrence 45 Carcinoma, Hepatocellular 45 Stomach Neoplasms 43 Pancreatic Neoplasms 40 Neoplasm Metastasis 39 Prostatic Neoplasms 34 Melanoma 34 Leukemia 30 Lymphoma, Non-Hodgkin 27 Lymphoma, B-Cell 27 Lung Neoplasms 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Glioblastoma 24 Ovarian Neoplasms 23 Lymphoma, Large B-Cell, Diffuse 21 Esophageal Neoplasms 21 Carcinoma, Renal Cell 20 Myelodysplastic Syndromes 19 Leukemia, Lymphocytic, Chronic, B-Cell 19 Hematologic Neoplasms 19 Colonic Neoplasms 19 Head and Neck Neoplasms 18 Lymphoma, Mantle-Cell 17

Interventions

Everolimus 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Unknown × Advanced Malignancies × Clear all

NCT01079702 2010-03-03

m-TOR

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Unknown

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡